STEPHEN MORDECAI KREITZER

Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease TAMPA, FL NPI 1659337491

General Payments — all program years on this page

$30,572.34

  • Category: General Payments
  • Program years: PY2018–2022
  • Record count: 56
  • As of (CMS publication): 2026-01-23

Latest program year (PY2022): $4,807.71 across 9 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2022) · sorted by reported total.

By paying entity

Latest program year (PY2022) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $4,644.025
GENZYME CORPORATION $120.681
JAZZ PHARMACEUTICALS INC. $31.322
HARMONY BIOSCIENCES LLC $11.691

By program year

Program yearAmountRecords
2018 $5,984.5814
2019 $146.644
2020 $1,915.3810
2021 $17,718.0319
2022 $4,807.719

Records — PY2022 (9)

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.